All In MedTech

Device Trial Radar · NCT01936272

Randomized Controlled Trial of Shunt vs ETV/CPC for PIH in Ugandan Infants

Neurocognitive Outcomes and Changes in Brain and Cerebral Spinal Fluid (CSF) Volume After Treatment of Post-Infectious Hydrocephalus (PIH) in Ugandan Infants by Shunting Versus ETV/CPC

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 100 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

100

Actual

Start

May 27, 2013

Primary completion

Jun 2026

Study completion Oct 2026

Sponsor

Lead sponsor
Boston Children's HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Penn State University; The Hospital for Sick Children; CURE Children's Hospital, Uganda; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
First posted
Sep 6, 2013

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Single group
Masking
Single (investigator)
Primary purpose
Treatment
Who can join
All sexes, from 1 day, up to 180 days
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Two treatment options exist for infant patients with hydrocephalus. Most patients are treated with a surgical procedure in which a shunt is inserted into the brain and abdomen. In recent years, however, another treatment has developed called Endoscopic Third Ventriculostomy (ETV) with Choroid Plexus Cauterization (ETV/CPC).This research study is being done to measure the results of these procedures in children less than six months of age who have hydrocephalus as the result of a brain infection, called post-infectious hydrocephalus, or PIH. This study will evaluate patients in more detail to measure brain growth and development.

Conditions

  • Hydrocephalus

Interventions

  • Chhabra Shunt PlacementDevice

  • ETV/CPCProcedure

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change of Age-normed Bayley Scales of Infant Development (BSID)-III scoresTime frame: 12 months and 24 months post treatment

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • CURE Children's Hospital Uganda

    Mbale, Uganda

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.